Skip to main content
AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
5.03
-0.08 (-1.57%)
At close: Feb 27, 2026, 4:00 PM EST
5.07
+0.04 (0.80%)
After-hours: Feb 27, 2026, 4:17 PM EST

AVITA Medical Revenue

In the year 2025, AVITA Medical had annual revenue of $71.61M with 11.45% growth. AVITA Medical had revenue of $17.62M in the quarter ending December 31, 2025, a decrease of -4.30%.

Revenue (ttm)
$71.61M
Revenue Growth
+11.45%
P/S Ratio
2.15
Revenue / Employee
$316,858
Employees
226
Market Cap
154.08M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202571.61M7.36M11.45%
Dec 31, 202464.25M14.11M28.14%
Dec 31, 202350.14M15.72M45.68%
Dec 31, 202234.42M1.40M4.23%
Dec 31, 202133.03M3.79M12.98%
Jun 30, 2021 Pro Pro Pro
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inogen 348.67M
Treace Medical Concepts 212.69M
InfuSystem Holdings 143.44M
Electromed 68.86M
LENSAR 59.14M
Apyx Medical 47.90M
SANUWAVE Health 41.28M
Rapid Micro Biosystems 30.52M
Revenue Rankings

RCEL News

More News